Bausch Health Companies Inc.
NYSE:BHCDrug Manufacturers - Specialty & Generic
-$0.11 today
- Market cap
- $3.27B
- Beta
- 0.41
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$3.19
Volume 6.83M
Average 1.70M
BHC Total Debt
Short-term and long-term borrowings combined.
Bausch Health Companies Inc.NYSE: BHC
Total Debt · Q2 FY2026 · quarter ended Jun 2026
Total debt falls 4.4% from a year ago
Total debt stood at $20.78B at the end of Q2 FY2026, down 4.4% from a year earlier and down 0.1% from the prior quarter. Over 3 fiscal years it compounded at +0.7% a year.
Context
- Total debt amounted to 83.8% of total assets at the end of Q2 FY2026, up 4.1 pp from a year earlier.
- Total debt increased in 1 of the last 3 fiscal years.
What to watch
Whether total debt keeps falling in the next quarterly balance sheet after a -4.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 21.21B USD
- Year-over-year change
- -2.8%
- 4-year CAGR
- -1.6%
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21.21B | -2.8% |
| FY2024 | 2024-12-31 | 21.83B | -2.5% |
| FY2023 | 2023-12-31 | 22.39B | +7.8% |
| FY2022 | 2022-12-31 | 20.77B | -8.3% |
| FY2021 | 2021-12-31 | 22.65B | — |
Total Debt vs competitors
How BHC compares with its peers on the latest reported figures
- BHC's Jun 2026 total debt of $20.78B is the highest of the 11 companies compared; the peer median is $750.96M.
- Its year-over-year change of -4.4% is the 7th highest of 10, against a peer median of -3.8%.
- Total debt amounts to 83.8% of total assets for BHC, versus a peer median of 33.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $20.78B | -4.4% | +0.7% | 83.8% | |
| Jun 2026 | $3.29B | -14.0% | -2.8% | 43.3% | |
| Mar 2026 | $2.33B | -3.8% | +4.8% | 44.6% | |
CONConcentra Group Holdings Parent, Inc. | Sep 2026 | $2.13B | -0.5% | +26.5% | 70.7% |
| Mar 2026 | $1.46B | +18.8% | +21.6% | 102.5% | |
| Jun 2026 | $1.17B | -4.1% | +16.9% | 49.6% | |
| Mar 2026 | $327.76M | -47.4% | +4.3% | 23.0% | |
| Jun 2026 | $247.36M | +59.8% | +18.0% | 17.8% | |
| Dec 2025 | $97.89M | +9.0% | +53.6% | 5.6% | |
| Jun 2026 | $97.62M | — | — | 14.6% | |
| Mar 2026 | $2.68M | -13.3% | -10.6% | 0.2% | |
| Peer median (excluding BHC) | $750.96M | -3.8% | +16.9% | 33.2% | |
Competitors are the stored peer set for BHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 582M | 564M | 947M | 1.18B | 1.32B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 1.78B | 1.79B | 2B | 2.14B | 2.35B |
| Inventory | 993M | 1.09B | 1.54B | 1.6B | 1.63B |
| Other Current Assets | 1.54B | 39M | 1.11B | 858M | 850.45M |
| Total Current Assets | 5.61B | 4.25B | 5.6B | 5.77B | 6.15B |
| Property, Plant & Equipment (Net) | 1.6B | 1.6B | 1.71B | 1.78B | 2.07B |
| Goodwill | 12.46B | 11.55B | 11.18B | 11.09B | 11.25B |
| Intangible Assets | 6.95B | 5.8B | 6.46B | 5.55B | 4.63B |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 2.25B | 2.17B | 2.1B | 1.97B | 1.84B |
| Other Non-current Assets | 340M | 326M | 307M | 363M | 377.31M |
| Total Non-current Assets | 23.6B | 21.44B | 21.75B | 20.75B | 20.17B |
| Total Assets | 29.2B | 25.69B | 27.35B | 26.52B | 26.32B |
| Account Payables | 407M | 521M | 719M | 656M | 598.91M |
| Short-term Debt | 0 | 432M | 450M | 2.67B | 296.46M |
| Tax Payables | 98M | 30M | 47M | 63M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.98B | 1.34B | 1.4B | 1.33B | 2.85B |
| Total Current Liabilities | 5.2B | 3.94B | 4.3B | 6.75B | 4.17B |
| Long-term Debt | 22.65B | 20.33B | 21.94B | 18.94B | 20.72B |
| Deferred Tax Liabilities | 529M | 202M | 163M | 128M | 146.73M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 855M | 949M | 1.03B | 857.49M | 711.7M |
| Total Non-current Liabilities | 24.04B | 21.49B | 23.13B | 20.09B | 21.77B |
| Total Liabilities | 29.24B | 25.43B | 27.43B | 26.85B | 25.94B |
| Common Stock | 10.32B | 10.39B | 10.42B | 10.49B | 10.5B |
| Retained Earnings | (8.96B) | (9.19B) | (9.78B) | (9.82B) | (9.65B) |
| Accumulated OCI | (1.92B) | (2.06B) | (1.88B) | (2.18B) | (1.76B) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 72M | 952M | 940M | 957M | 929.31M |
| Total Equity | (34M) | 260M | (82M) | (322M) | 376.31M |
| Total Debt | 22.65B | 20.77B | 22.39B | 21.83B | 21.21B |
| Net Debt | 22.07B | 20.2B | 21.44B | 20.65B | 19.88B |
Bausch Health Companies Inc.
NYSE:BHC
Intrinsic Alpha fair value
Locked
Current Price
$8.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.